From the publishers of JADPRO

CAR T-Cell Therapy Resource Center

Advertisement

Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic

A CAR T-cell consortium addressed questions and concerns regarding cellular therapy administration in the setting of COVID-19 and provided general recommendations. It is the investigators’ opinion that the COVID-19 pandemic should not serve as a reason to defer CAR T-cell therapy for patients truly in need of a potentially curative therapy.

Biology of Blood and Marrow Transplantation
Advertisement
News & Literature Highlights
Advertisement
Advertisement